GGrantIndex
Sort

64,565 grants matching drug discovery

Novel Therapy to Inhibit IPMN Progression

$655,860
Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Development of antibacterial agents and materials

$655,823
Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damage

$655,803
Ivan Rusyn · Texas A&M Agrilife Research · R01 · FY2022 · ES

PRETARGETING WITH ANTI-CEA MABS FOR THERAPY

$655,780
Paul Yazaki · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA

Project 1: Targeting Oncogenic Transcription Factors

$655,771
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2024 · CA

Consomic rat panels for pharmacogenomic studies and target identification

$655,680
Steven H Nye · Physiogenix, Inc. · R44 · FY2008 · RR

INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS

$655,631
Cambria Biosciences, Llc · U01 · FY2003 · AI

SCI: Collaborative Research: DAPLDS - a Dynamically Adaptive Protein-Ligand Docking System based on Multi-Scale Modeling

$655,626
Michela Taufer · University Of Texas At El Paso · · FY2005 · CSE

Natural Product Derived Inhibitors of ESKAPE Pathogens

$655,589
Bill J Baker · University Of South Florida · R56 · FY2020 · AI

HTS of small molecule-protein interactions (RMI)

$655,514
Harvard University (Medical School) · R01 · FY2005 · HG

Optimizing Beta-Adrenoceptor Signaling Bias in Asthma

$655,249
Julia K L Walker · Duke University · R01 · FY2015 · AI

Deciphering the genetic mechanisms of atrial fibrillation

$655,247
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2020 · HL

In Vitro Core

$655,151
Michael A Hoffman · University Of Wisconsin-Madison · U19 · FY2016 · AI

Clinical and Translational Science Award

$655,128
Robert Stanley Sherwin · Yale University · KL2 · FY2006 · RR

Exploring the metabolism of non-replicating and drug-resistant TB

$655,103
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Development of Fluorescent False Neurotransmitters

$655,055
Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2021 · MH

Tissue ProcessingSequencing Facility

$654,952
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics

$654,934
Holly C. Hagan · New York University · R01 · FY2016 · DA

High-dimensional Modeling of PET for radiomic Biomarker Discovery

$654,860
Ani Eloyan · Brown University · R01 · FY2025 · AG

In vitro core

$654,825
F. Michael Hoffmann · University Of Wisconsin-Madison · U19 · FY2019 · AI

Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer

$654,763
Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2024 · CA

Carbon Nanotube Probes for Direct DNA Sequence Analysis

$654,701
Harvard University · R33 · FY2003 · CA

Mechanisms of FGF Receptor Regulation and Signaling

$654,682
Moosa Mohammadi · New York University School Of Medicine · R01 · FY2017 · DE

Center for Environment-Mediated Drug Resistance in Pediatric Cancer

$654,642
Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2015 · CA

Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD

$654,638
Sua Myong · Boston Children'S Hospital · R01 · FY2024 · AG